Akebia Therapeutics, Inc. - Penyata Pendapatan (TTM)

Akebia Therapeutics, Inc.
US ˙ NasdaqCM ˙ US00972D1054

Penyata Pendapatan (TTM)

Akebia Therapeutics, Inc. Penyata Pendapatan menunjukkan perubahan dalam pendapatan dan perbelanjaan sepanjang tempoh masa tertentu. Data Penyata Pendapatan termasuk Jualan dan Hasil, Untung Kasar, Penyelidikan dan Pembangunan (R&D), Jualan, Perbelanjaan Am dan Pentadbiran (SG&A), Pendapatan Operasi, Perbelanjaan Cukai Pendapatan, Perbelanjaan Faedah, Pendapatan Bukan Operasi, Perolehan sesaham (EPS), dan Saham Diterbitkan.

Semua nombor adalah kali 1,000,000 kecuali setiap unit saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Hasil 308 295 259 222 211 212 221 294 294 292 271 201 194 195 187 174 170 160 185 204
Perubahan (%) -4.39 -12.05 -14.37 -5.06 0.46 4.40 33.24 -0.01 -0.64 -7.39 -25.84 -3.32 0.21 -3.80 -6.80 -2.65 -5.71 15.44 10.18
% daripada Hasil 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Kos jualan 308 282 238 246 232 229 252 207 223 22 -15 9 -11 40 31 30 26 26 32 34
Perubahan (%) -8.44 -15.58 3.26 -5.58 -1.34 9.72 -17.92 8.18 -89.93 -165.35 -162.52 -219.23 -462.85 -21.87 -4.09 -13.24 1.14 20.84 8.20
% daripada Hasil 100.11 95.86 92.01 110.95 110.35 108.36 113.88 70.16 75.91 7.69 -5.43 4.58 -5.64 20.43 16.59 17.08 15.22 16.32 17.09 16.78
Keuntungan Operasi Kasar -0 12 21 -24 -22 -18 -31 88 71 270 286 192 205 155 156 145 144 134 153 170
Perubahan (%) -3,818.29 69.72 -217.38 -10.29 -18.81 73.36 -386.40 -19.28 280.67 5.77 -32.88 7.03 -24.52 0.84 -7.34 -0.47 -6.94 14.39 10.59
% daripada Hasil -0.11 4.14 7.99 -10.95 -10.35 -8.36 -13.88 29.84 24.09 92.31 105.43 95.42 105.64 79.57 83.41 82.92 84.78 83.68 82.91 83.22
SG&A 159 154 157 163 170 174 177 168 153 139 119 114 105 100 101 100 104 107 107 106
Perubahan (%) -2.81 2.07 3.92 3.78 2.65 1.86 -5.31 -8.61 -9.70 -14.08 -4.37 -8.06 -4.27 0.38 -0.12 3.79 2.15 0.29 -0.34
% daripada Hasil 51.45 52.30 60.70 73.66 80.53 82.28 80.27 57.05 52.14 47.39 43.97 56.69 53.91 51.50 53.74 57.59 61.40 66.52 57.78 52.27
R&D 130 131 100 85 63 53 41 36 38 38 41
Perubahan (%) 0.51 -23.46 -14.70 -26.06 -15.78 -23.62 -11.94 5.38 0.06 8.93
% daripada Hasil 44.44 48.24 49.79 43.93 32.41 28.37 23.25 21.03 23.51 20.37 20.14
OpEx 500 469 427 441 436 440 465 411 413 327 271 259 215 239 221 207 202 206 203 200
Perubahan (%) -6.25 -8.95 3.24 -1.05 0.73 5.81 -11.72 0.59 -20.79 -17.13 -4.41 -16.99 11.17 -7.64 -6.31 -2.41 2.21 -1.57 -1.68
% daripada Hasil 162.40 159.23 164.84 198.73 207.13 207.67 210.47 139.45 140.29 111.84 100.08 129.00 110.76 122.86 117.96 118.58 118.87 128.85 109.86 98.04
Pendapatan operasi -192 -175 -168 -219 -226 -228 -244 -116 -119 -35 -0 -58 -21 -44 -34 -32 -32 -46 -18 4
Perubahan (%) -9.24 -3.73 30.40 3.01 0.97 7.12 -52.42 2.12 -70.80 -99.37 26,595.78 -64.14 112.98 -24.43 -3.60 -1.12 44.15 -60.52 -121.92
% daripada Hasil -62.40 -59.23 -64.84 -98.73 -107.13 -107.67 -110.47 -39.45 -40.29 -11.84 -0.08 -29.00 -10.76 -22.86 -17.96 -18.58 -18.87 -28.85 -9.86 1.96
Perbelanjaan Faedah -8 -9 -12 -14 -17 -20 -20 -20 -19 -16 -12 -9 -6 -6 -7 -7 -13 -18 -23 -28
Perubahan (%) 9.25 31.77 22.59 19.51 16.26 1.28 0.36 -5.57 -18.36 -22.32 -27.85 -28.91 -3.49 15.53 7.26 70.25 42.90 28.99 19.97
% daripada Hasil -2.65 -3.03 -4.53 -6.49 -8.17 -9.46 -9.18 -6.91 -6.53 -5.36 -4.50 -4.38 -3.22 -3.10 -3.72 -4.28 -7.49 -11.35 -12.69 -13.81
Pendapatan bersih -391 -385 -392 -300 -299 -282 -276 -163 -158 -94 -58 -98 -59 -52 -43 -40 -46 -69 -45 -36
Perubahan (%) -1.56 1.94 -23.63 -0.14 -5.73 -2.15 -40.76 -3.33 -40.37 -38.88 70.53 -40.33 -11.41 -17.12 -6.02 13.72 50.92 -34.72 -19.48
% daripada Hasil -126.86 -130.61 -151.39 -135.00 -142.00 -133.25 -124.88 -55.52 -53.68 -32.22 -21.26 -48.89 -30.18 -26.68 -22.99 -23.18 -27.07 -43.33 -24.51 -17.91

Source: Capital IQ

Other Listings
DE:AX9 €2.53
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista